Dr. Sandeep Kumar Singh is Assistant Professor in the All India Institute of Medical Sciences (AIIMS), Nagpur, India. He obtained his PhD in Biotechnology from Banaras Hindu University and conducted postdoctoral research in the Department of Neurobiology at the University of Chicago. Dr. Singh brings 17 years of experience in neuroscience, molecular biology, neurodegenerative diseases, aging, nutraceuticals, and nanomedicines. He is a member of several scientific societies, including the American Academy of Neurology, International Society of Neurochemistry, Society of Neurochemistry, Indian Academy of Neurosciences, and Alzheimer’s and related Disorders Society of India. Dr. Singh has published five books, including Elsevier’s A New Era in Alzheimer’s Research and Genome Editing for Neurodegenerative Diseases.A Professor of Neurology at the University of Chile and Director and General of the International Center for Biomedicine. A world-class scientist, ranked in the top 1% of researchers in the world and widely recognized by his peers. His investigations allowed to open a new paradigm demonstrating the neuroinflammatory basis of Alzheimer´s disease (Theory of neuroimmunomodulation). This theory has allowed technologies to advance hand in hand with innovative tools that allowed him to generate an innovative biomarker that detect Alzheimers 10 years before its clinical phase.

• 1. Unveiling the complexity of Alzheimer’s disease: Introduction and its pathophysiologySHABNAM SHABIR AND MAHENDRA P. SINGH2. Microglia, mitochondria, and inflammatory events in neurotoxicity of Alzheimer’s diseasePRITI GUPTA AND T.S. GOPENATH3. Biomarkers used in Alzheimer’s disease diagnosisSHAILENDRA KUMAR MISHRA, HUNG-MING CHANG, AHMAD A. OBAID, AND SANDEEP KUMAR SINGH4. Molecular and neuroimaging biomarkers in the diagnosis of Alzheimer’s diseasePAALKI SETHI, KRISHNA KUMAR SINGH, APARAJITA DASGUPTA AMIST, M.P. SINGH, JITENDRA KUMAR SINHA, AND SHAMPA GHOSH5. The genetic basis of neurodegenerative disorders: Implications in Alzheimer’s diseaseMD GULAM JILANI, MEHBOOB HOQUE, SHAMS TABREZ, AND SAFDAR ALI6. Current status of prevention strategies adapted for Alzheimer’s diseaseABHINAV SINGH, PAALKI SETHI, SHAMPA GHOSH, KRISHNA KUMAR SINGH, SACHIN ROHATGI, PRAVEEN SINGH, AND JITENDRA KUMAR SINHA7. Treatment strategies used for Alzheimer’s diseaseKOYEL KAR8. Cerebrovascular pathology and targets for the prevention of Alzheimer’s diseasePOONAM SHEORAN, RAHUL DEV TRIPATHI, SHAILENDRA KUMAR MISHRA, TANMOY GHATAK, AND SANDEEP KUMAR SINGH9. Is the controversy between Baptists and Taoists still present?ANISHA BHOLA, KAMEEV SHARMA, SHAMPA GHOSH, KRISHNA KUMAR SINGH, RAKESH BHASKAR, AND JITENDRA KUMAR SINHA10. Nutraceuticals in the prevention and treatment of Alzheimer’s diseaseDEVESH KUMAR MISHRA, SHAILENDRA KUMAR MISHRA, AMIT ASTHANA, KHOLIS ABDURACHIM AUDAH, MAHENDRA P. SINGH, AND SANDEEP KUMAR SINGH11. Physical exercise and lifestyle management: Preventive measures for Alzheimer’s diseasePRADEEP KUMAR MISHRA, SHAMPA GHOSH, KRISHNA KUMAR SINGH, AND JITENDRA KUMAR SINHA12. Brain insulin resistance and deficiency in Alzheimer’s disease: Role in the pathophysiology and the potential pharmacological targetsOLUSEGUN ADEBAYO ADEOLUWA, IBIFIRI PRECIOUS JACK, OLUWAFERANMI JOSEPH ATOLAGBE, AND CHRISTOPHER OKABA13. Different drugs used as therapeutic targets against AD till dateMANISHA NAHAR, AAMIR KHAN, RAVINA RAI, AND DEEPALI JAT14. Future perspectives on the clinics of Alzheimer’s diseasePRADEEP KUMAR MISHRA, KRISHNA KUMAR SINGH, SHAMPA GHOSH, AND JITENDRA KUMAR SINHA15. AD prevention strategies adapted till presentRAYEES AHMAD NAIK, MEHAK NASEER MIR, ROSHNI RAJPOOT, SONALIKA SINGH, KUSUM SINGH, AND SANDEEP KUMAR SINGH

Dr. Sandeep Kumar Singh is Assistant Professor in the All India Institute of Medical Sciences (AIIMS), Nagpur, India. He obtained his PhD in Biotechnology from Banaras Hindu University and conducted postdoctoral research in the Department of Neurobiology at the University of Chicago. Dr. Singh brings 17 years of experience in neuroscience, molecular biology, neurodegenerative diseases, aging, nutraceuticals, and nanomedicines. He is a member of several scientific societies, including the American Academy of Neurology, International Society of Neurochemistry, Society of Neurochemistry, Indian Academy of Neurosciences, and Alzheimer’s and related Disorders Society of India. Dr. Singh has published five books, including Elsevier’s A New Era in Alzheimer’s Research and Genome Editing for Neurodegenerative Diseases.A Professor of Neurology at the University of Chile and Director and General of the International Center for Biomedicine. A world-class scientist, ranked in the top 1% of researchers in the world and widely recognized by his peers. His investigations allowed to open a new paradigm demonstrating the neuroinflammatory basis of Alzheimer´s disease (Theory of neuroimmunomodulation). This theory has allowed technologies to advance hand in hand with innovative tools that allowed him to generate an innovative biomarker that detect Alzheimers 10 years before its clinical phase.

• 1. Unveiling the complexity of Alzheimer’s disease: Introduction and its pathophysiologySHABNAM SHABIR AND MAHENDRA P. SINGH2. Microglia, mitochondria, and inflammatory events in neurotoxicity of Alzheimer’s diseasePRITI GUPTA AND T.S. GOPENATH3. Biomarkers used in Alzheimer’s disease diagnosisSHAILENDRA KUMAR MISHRA, HUNG-MING CHANG, AHMAD A. OBAID, AND SANDEEP KUMAR SINGH4. Molecular and neuroimaging biomarkers in the diagnosis of Alzheimer’s diseasePAALKI SETHI, KRISHNA KUMAR SINGH, APARAJITA DASGUPTA AMIST, M.P. SINGH, JITENDRA KUMAR SINHA, AND SHAMPA GHOSH5. The genetic basis of neurodegenerative disorders: Implications in Alzheimer’s diseaseMD GULAM JILANI, MEHBOOB HOQUE, SHAMS TABREZ, AND SAFDAR ALI6. Current status of prevention strategies adapted for Alzheimer’s diseaseABHINAV SINGH, PAALKI SETHI, SHAMPA GHOSH, KRISHNA KUMAR SINGH, SACHIN ROHATGI, PRAVEEN SINGH, AND JITENDRA KUMAR SINHA7. Treatment strategies used for Alzheimer’s diseaseKOYEL KAR8. Cerebrovascular pathology and targets for the prevention of Alzheimer’s diseasePOONAM SHEORAN, RAHUL DEV TRIPATHI, SHAILENDRA KUMAR MISHRA, TANMOY GHATAK, AND SANDEEP KUMAR SINGH9. Is the controversy between Baptists and Taoists still present?ANISHA BHOLA, KAMEEV SHARMA, SHAMPA GHOSH, KRISHNA KUMAR SINGH, RAKESH BHASKAR, AND JITENDRA KUMAR SINHA10. Nutraceuticals in the prevention and treatment of Alzheimer’s diseaseDEVESH KUMAR MISHRA, SHAILENDRA KUMAR MISHRA, AMIT ASTHANA, KHOLIS ABDURACHIM AUDAH, MAHENDRA P. SINGH, AND SANDEEP KUMAR SINGH11. Physical exercise and lifestyle management: Preventive measures for Alzheimer’s diseasePRADEEP KUMAR MISHRA, SHAMPA GHOSH, KRISHNA KUMAR SINGH, AND JITENDRA KUMAR SINHA12. Brain insulin resistance and deficiency in Alzheimer’s disease: Role in the pathophysiology and the potential pharmacological targetsOLUSEGUN ADEBAYO ADEOLUWA, IBIFIRI PRECIOUS JACK, OLUWAFERANMI JOSEPH ATOLAGBE, AND CHRISTOPHER OKABA13. Different drugs used as therapeutic targets against AD till dateMANISHA NAHAR, AAMIR KHAN, RAVINA RAI, AND DEEPALI JAT14. Future perspectives on the clinics of Alzheimer’s diseasePRADEEP KUMAR MISHRA, KRISHNA KUMAR SINGH, SHAMPA GHOSH, AND JITENDRA KUMAR SINHA15. AD prevention strategies adapted till presentRAYEES AHMAD NAIK, MEHAK NASEER MIR, ROSHNI RAJPOOT, SONALIKA SINGH, KUSUM SINGH, AND SANDEEP KUMAR SINGH

Dr. Sandeep Kumar Singh is Assistant Professor in the All India Institute of Medical Sciences (AIIMS), Nagpur, India. He obtained his PhD in Biotechnology from Banaras Hindu University and conducted postdoctoral research in the Department of Neurobiology at the University of Chicago. Dr. Singh brings 17 years of experience in neuroscience, molecular biology, neurodegenerative diseases, aging, nutraceuticals, and nanomedicines. He is a member of several scientific societies, including the American Academy of Neurology, International Society of Neurochemistry, Society of Neurochemistry, Indian Academy of Neurosciences, and Alzheimer’s and related Disorders Society of India. Dr. Singh has published five books, including Elsevier’s A New Era in Alzheimer’s Research and Genome Editing for Neurodegenerative Diseases.A Professor of Neurology at the University of Chile and Director and General of the International Center for Biomedicine. A world-class scientist, ranked in the top 1% of researchers in the world and widely recognized by his peers. His investigations allowed to open a new paradigm demonstrating the neuroinflammatory basis of Alzheimer´s disease (Theory of neuroimmunomodulation). This theory has allowed technologies to advance hand in hand with innovative tools that allowed him to generate an innovative biomarker that detect Alzheimers 10 years before its clinical phase.

• 1. Unveiling the complexity of Alzheimer’s disease: Introduction and its pathophysiologySHABNAM SHABIR AND MAHENDRA P. SINGH2. Microglia, mitochondria, and inflammatory events in neurotoxicity of Alzheimer’s diseasePRITI GUPTA AND T.S. GOPENATH3. Biomarkers used in Alzheimer’s disease diagnosisSHAILENDRA KUMAR MISHRA, HUNG-MING CHANG, AHMAD A. OBAID, AND SANDEEP KUMAR SINGH4. Molecular and neuroimaging biomarkers in the diagnosis of Alzheimer’s diseasePAALKI SETHI, KRISHNA KUMAR SINGH, APARAJITA DASGUPTA AMIST, M.P. SINGH, JITENDRA KUMAR SINHA, AND SHAMPA GHOSH5. The genetic basis of neurodegenerative disorders: Implications in Alzheimer’s diseaseMD GULAM JILANI, MEHBOOB HOQUE, SHAMS TABREZ, AND SAFDAR ALI6. Current status of prevention strategies adapted for Alzheimer’s diseaseABHINAV SINGH, PAALKI SETHI, SHAMPA GHOSH, KRISHNA KUMAR SINGH, SACHIN ROHATGI, PRAVEEN SINGH, AND JITENDRA KUMAR SINHA7. Treatment strategies used for Alzheimer’s diseaseKOYEL KAR8. Cerebrovascular pathology and targets for the prevention of Alzheimer’s diseasePOONAM SHEORAN, RAHUL DEV TRIPATHI, SHAILENDRA KUMAR MISHRA, TANMOY GHATAK, AND SANDEEP KUMAR SINGH9. Is the controversy between Baptists and Taoists still present?ANISHA BHOLA, KAMEEV SHARMA, SHAMPA GHOSH, KRISHNA KUMAR SINGH, RAKESH BHASKAR, AND JITENDRA KUMAR SINHA10. Nutraceuticals in the prevention and treatment of Alzheimer’s diseaseDEVESH KUMAR MISHRA, SHAILENDRA KUMAR MISHRA, AMIT ASTHANA, KHOLIS ABDURACHIM AUDAH, MAHENDRA P. SINGH, AND SANDEEP KUMAR SINGH11. Physical exercise and lifestyle management: Preventive measures for Alzheimer’s diseasePRADEEP KUMAR MISHRA, SHAMPA GHOSH, KRISHNA KUMAR SINGH, AND JITENDRA KUMAR SINHA12. Brain insulin resistance and deficiency in Alzheimer’s disease: Role in the pathophysiology and the potential pharmacological targetsOLUSEGUN ADEBAYO ADEOLUWA, IBIFIRI PRECIOUS JACK, OLUWAFERANMI JOSEPH ATOLAGBE, AND CHRISTOPHER OKABA13. Different drugs used as therapeutic targets against AD till dateMANISHA NAHAR, AAMIR KHAN, RAVINA RAI, AND DEEPALI JAT14. Future perspectives on the clinics of Alzheimer’s diseasePRADEEP KUMAR MISHRA, KRISHNA KUMAR SINGH, SHAMPA GHOSH, AND JITENDRA KUMAR SINHA15. AD prevention strategies adapted till presentRAYEES AHMAD NAIK, MEHAK NASEER MIR, ROSHNI RAJPOOT, SONALIKA SINGH, KUSUM SINGH, AND SANDEEP KUMAR SINGH